Programs Search and Views Navigation
January 2023
- ONLINE ON-DEMAND
Tackling Migraine Head On: The Role of Gepants in Migraine Treatment and Prevention
When should gepants be recommended for the prevention or treatment of migraines? Join migraine expert Jessica Ailani, MD, for this 30-minute podcast discussing recommendations for the use of acute and preventive migraine therapies, efficacy and safety data on gepants for migraine, and recommending gepants for migraine according to patient- and disease-specific factors. Click the link below to access the course: https://learning.freecme.com/a/40897PAnTdRM
Find out more »November 2022
- ONLINE ON-DEMAND
Raising the Bar for Patient Outcomes With Immunotherapy in Early-Stage Resectable NSCLC
Are you familiar with the role of immunotherapy for non-small cell lung cancer (NSCLC)? In this activity, learners will be immersed in two NSCLC patient cases with interspersed faculty commentary and engaging questions. Upon completion, learners will be better able to select patients with NSCLC who may derive benefit from immunotherapy and recommend immunotherapy according to recent clinical trial data. Click the link below to access the course: https://learning.freecme.com/a/40555PAURpd6
Find out more »- ONLINE ON-DEMAND
Ace the Case: Improving Mental Health in Patients With MS to Positively Impact Adherence and Outcomes
Are you familiar with the impact of mental health disorders on outcomes for patients with multiple sclerosis (MS)? Join neuropsychiatry expert Jonathan Howard, MD, in this case-based educational activity focused on educating clinicians on the impact of depression and other mental health disorders on patients with MS, identifying opportunities for care collaboration in MS management, and creating patient-specific care strategies for patients with MS to optimize treatment regimens. Click the link below to access the course: https://cme.healio.com/neurology/ace-the-case/20220923/improving-mental-health-in-patients-with-ms-to-positively-impact-adherence-and-outcomes/overview
Find out more »- ONLINE ON-DEMAND
Atopic Dermatitis: Important Advances in JAK Treatments
Are you familiar with the role of Janus kinase (JAK) inhibitors for atopic dermatitis (AD)? With over half of patients with AD reporting insufficient disease control, therapeutic management is challenging. In this activity, a dermatology expert explores the rationale behind JAK inhibition for the treatment of AD, clinical trial data on JAK inhibitors for AD, and considering JAK inhibitors when determining patient-specific management of this complex disease. Click the link below to access the course: https://www.rapidcme.com/activity.aspx?actID=94
Find out more »